EGFR and neoplasm: Because the TKI resistant lines showed high phospho-EGFR levels (Fig. 2A,D and G) and because of the crucial roles of YAP in supporting tumor survival in the presence of TKIs, we next aimed to identify whether YAP is an ideal target for combined inhibition with EGFR TKI.